- Baseline risk of recurrence in stage I–II endometrial carcinoma
-
Sasada S, Yunokawa M, Takehara Y, Ishikawa M, Ikeda S, Kato T, Tamura K
- KMID: 2395236
- J Gynecol Oncol.
- 2018 Jan;29(1):e9.
- doi: 10.3802/jgo.2018.29.e9
OBJECTIVE: Though there are no evidences that postoperative therapy improves overall survival (OS) in stage I–II endometrial carcinoma, many women receive postoperative radiation or chemotherapy. This study aimed to investigate... -
- CITED
-
- Close
- SHARE
-
- Close
- A novel prediction score for predicting the baseline risk of recurrence of stage I–II endometrial carcinoma
-
Takahashi , Yunokawa M, Sasada S, Takehara Y, Miyasaka N, Kato T, Tamura K
- KMID: 2429577
- J Gynecol Oncol.
- 2019 Jan;30(1):e8.
- doi: 10.3802/jgo.2019.30.e8
OBJECTIVE: To develop and validate a 3-year recurrence prediction score (RPS) system for predicting the baseline risk of recurrence of stage I–II endometrial carcinoma. METHODS: We reviewed 427 patients with International... -
- CITED
-
- Close
- SHARE
-
- Close
